Gencor reports that a new study that has been submitted for publication found that its proprietary fenugreek extract, Testofen, increased strength, endurance, and lean body mass is healthy, active males.
Photo © iStockphoto.com
A new unpublished study shows that Gencor’s (Irvine, CA) proprietary fenugreek extract (Testofen) increases strength, aerobic endurance, and lean body mass in healthy, active men. The double-blind, randomized, dose response, eight-week clinical trial was conducted at RDC Global with 138 healthy, non-smoking male subjects, and examined changes in lean body mass, fat mass, upper and lower body muscular strength, and endurance. Results showed that the extract acted in a dose-response manner, with 600 mg per day of Testofen in conjunction with an effective exercise routine demonstrating superior positive effects when compared to placebo, or 300 mg of Testofen per day.
“These significant and positive results show that Testofen may be an effective ergogenic aid for those wanting to rapidly improve their exercise performance and body composition above and beyond exercise training only,” said Chase Shryoc, vice president of sales and business development for Gencor, in a press release. “We are thrilled about the results of this study and look forward to incorporating Testofen into its next sports nutrition product.”
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.